News | June 08, 2022
ANG Lifesciences India Q4 FY 22 net profit soars to Rs. 5.28 Cr
The company has posted net profit of Rs.39.71 crores for the Financial Year ended March 31, 2022.
The company has posted net profit of Rs.39.71 crores for the Financial Year ended March 31, 2022.
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022
The company will provide free Diagnostics Service- X-ray Tele Radiology Services in District Hospitals / Sub-district Hospitals / Community Health Centers in the State of Tripura.
The new subsidiary follows the recent announcement of Tetra's partnership with Cannvalate Pty Ltd for the performance of clinical trials of Tetra's drug candidates in Australia.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit
Scemblix (asciminib) continues to show superior efficacy with more-than-two-fold improvement in major molecular response rate vs. Bosulif (bosutinib) at 96 weeks
Subscribe To Our Newsletter & Stay Updated
